Classes
Publications
- Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer2019 | First Faculty of Medicine
- Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer +12018 | First Faculty of Medicine, Second Faculty of Medicine
- Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer2018 | First Faculty of Medicine
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study2018 | First Faculty of Medicine
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The Inclusion of a Gemcitabine Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine
- Trefoil factor family (TFF) proteins as potential serum biomarkers in patients with metastatic colorectal cancer2015 | First Faculty of Medicine
- Immunoscore and its predictive value for colorectal cancer2015 | First Faculty of Medicine
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
Loading network view...